Jeff Yass’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63K Buy
4,788
+3,091
+182% +$69K ﹤0.01% 12748
2026
Q1
$44.6K Buy
1,697
+591
+53% +$74.3K ﹤0.01% 12665
2025
Q4
$274K Buy
+1,106
New +$252K ﹤0.01% 10155
2025
Q3
– Sell
-4,783
Closed -$843K – 12970
2025
Q2
$471K Sell
4,783
-31,668
-87% -$2.76M ﹤0.01% 9316
2025
Q1
$3.21M Buy
36,451
+29,228
+405% +$2.7M ﹤0.01% 4521
2024
Q4
$523K Buy
7,223
+2,836
+65% +$194K ﹤0.01% 8554
2024
Q3
$346K Buy
4,387
+217
+5% +$16.7K ﹤0.01% 9293
2024
Q2
$301K Sell
4,170
-18,485
-82% -$1.11M ﹤0.01% 9442
2024
Q1
$2.14M Buy
22,655
+16,407
+263% +$1.44M ﹤0.01% 5178
2023
Q4
$456K Sell
6,248
-806
-11% -$47.6K ﹤0.01% 8900
2023
Q3
$470K Sell
7,054
-2,321
-25% -$214K ﹤0.01% 8370
2023
Q2
$900K Sell
9,375
-15,101
-62% -$1.5M ﹤0.01% 6934
2023
Q1
$2.47M Buy
24,476
+21,107
+627% +$3.23M ﹤0.01% 4713
2022
Q4
$585K Buy
3,369
+2,201
+188% +$1.45M ﹤0.01% 7438
2022
Q3
$1.12M Buy
+1,168
New +$1.16M ﹤0.01% 6338
2022
Q2
– Sell
-651
Closed -$404K – 13273
2022
Q1
$452K Sell
651
-267
-29% -$206K ﹤0.01% 9229
2021
Q4
$831K Buy
918
+428
+87% +$407K ﹤0.01% 7788
2021
Q3
$493K Sell
490
-481
-50% -$354K ﹤0.01% 9435
2021
Q2
$631K Buy
971
+131
+16% +$90.9K ﹤0.01% 8997
2021
Q1
$621K Sell
840
-783
-48% -$632K ﹤0.01% 8969
2020
Q4
$1.26M Buy
1,623
+88
+6% +$69.3K ﹤0.01% 6156
2020
Q3
$1.52M Buy
+1,535
New +$1.63M ﹤0.01% 5147
2020
Q2
– Sell
-1,202
Closed -$1.21M – 10403
2020
Q1
$976K Buy
+1,202
New +$1.26M ﹤0.01% 5465
2019
Q4
– Sell
-635
Closed -$1.02M – 10036
2019
Q3
$853K Buy
+635
New +$1.01M ﹤0.01% 6046

Other funds holding GOSS

Jeff Yass's GOSS Position: Q2 2026 in Review

Jeff Yass increased its Gossamer Bio (GOSS) stake by 182% in Q2 2026, buying an estimated $69K and bringing the position to 4,788 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #12748.

Jeff Yass first reported a position in GOSS in Q3 2019 and has held it in 24 quarters since. The position peaked at $3.21M in Q1 2025. 167 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Jeff Yass held 4,788 shares of Gossamer Bio worth $63K as of Q2 2026.
  • Jeff Yass bought 3,091 Gossamer Bio shares in Q2 2026, an estimated $69K.
  • Gossamer Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12748 holding.
  • Jeff Yass first reported a position in Gossamer Bio in Q3 2019 and has held it in 24 quarters since.
  • Jeff Yass's Gossamer Bio position peaked at $3.21M in Q1 2025.
  • 167 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.